A new cancer-detecting tool uses tiny circuits made of DNA to identify cancer cells by the molecular signatures on their surface.
Duke University researchers fashioned the simple circuits from interacting strands of synthetic DNA that are tens of thousands of times finer than a human hair.
Unlike the circuits in a computer, these circuits work by attaching to the outside of a cell and analyzing it for proteins found in greater numbers on some cell types than others. If a circuit finds its targets, it labels the cell with a tiny light-up tag.
Because the devices distinguish cell types with higher specificity than previous methods, the researchers hope their work might improve diagnosis, and give cancer therapies better aim.
A team led by Duke computer scientist John Reif and his former Ph.D. student Tianqi Song described their approach in a recent issue of the Journal of the American Chemical Society.
Similar techniques have been used previously to detect cancer, but they’re more prone to false alarms — misidentifications that occur when mixtures of cells sport one or more of the proteins a DNA circuit is designed to screen for, but no single cell type has them all.
For every cancer cell that is correctly detected using current methods, some fraction of healthy cells also get mislabeled as possibly cancerous when they’re not.
Each type of cancer cell has a characteristic set of cell membrane proteins on its cell surface. To cut down on cases of mistaken identity, the Duke team designed a DNA circuit that must latch onto that specific combination of proteins on the same cell to work.
As a result they’re much less likely to flag the wrong cells, Reif said.
The technology could be used as a screening tool to help rule out cancer, which could mean fewer unnecessary follow-ups, or to develop more targeted cancer treatments with fewer side effects.
Each basic element of their DNA circuit consists of two DNA strands. The first DNA strand folds over and partially pairs up with itself to form a hairpin shape. One end of each hairpin is bound to a second strand of DNA that acts as a lock and tether, folding in such a way to fit a specific cell surface protein like a puzzle piece. Together these two strands act to verify that that particular protein is present on the cell surface.
To look for cancer, the circuit components are mixed with a person’s cells in the lab. If any cells are studded with the right combination of proteins, the complete circuit will attach. Adding a strand of “initiator” DNA then causes one of the hairpins to open, which in turn triggers another in a chain reaction until the last hairpin in the circuit is opened and the cell lights up.
Test runs of the device in test tubes in Reif’s lab showed it can be used to detect leukemia cells and to distinguish them from other types of cancer within a matter of hours, just by the strength of their glow.
The devices can be easily reconfigured to detect different cell surface proteins by replacing the tether strands, the researchers say. In the future, Reif plans to expand the device to release a small molecule that alerts the body’s immune system to attack the cancer cell.
The technology isn’t ready for prime time yet. The researchers say their DNA circuits require testing in more realistic conditions to make sure they still flag the right cells.
But it’s a promising step toward ensuring that cancer screens and therapies zero in on the right culprits.
Learn more: I.D. VERIFICATION, NOW FOR CANCER
The Latest Google Headlines on:
DNA devices
[google_news title=”” keyword=”DNA devices” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
DNA devices
- The New York Sunon April 30, 2024 at 6:43 pm
Over the last couple years, according to Mr. Sills, as DNA technology has rapidly improved, articles of clothing have been sent to labs in Texas and Utah as potential evidence. And, promisingly enough ...
- Latest biotech cuts hit pioneering DNA sequencing company, Verily's eye-focused joint ventureon April 30, 2024 at 2:55 pm
Twenty/Twenty Therapeutics LLC — a joint venture between Alphabet's (NASDAQ: GOOG) Verily Life Sciences unit and Santen Pharmaceutical Co. Ltd. of Osaka — will be shuttered, the company said in a ...
- At-home DNA test reveals man’s unusual Neanderthal connectionon April 29, 2024 at 8:36 am
Jori Waskahat did an at-home DNA test and found out that he had a Neanderthal DNA. His Instagram post went viral and sparked a much larger discussion.
- Man Does DNA Test, Not Prepared For What Comes Back 'Unusually High'on April 27, 2024 at 7:00 am
The designer's genetic profile showed an astonishing amount of Neanderthal DNA, which has captured the attention of millions online—and a scientist.
- Here is a look at one of the labs that helped uncover new DNA evidence in Lake Oconee murderon April 25, 2024 at 2:07 pm
Police don’t believe the father knew about the pregnancy, but that lead helped them identify Baby India’s biological mother, 40-year-old Karima Juani, who has now been charged with attempted murder, ...
- Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Programon April 25, 2024 at 5:24 am
Under the terms of the contract, Applied DNA will supply Linea™ DNA IVT templates to HDT Bio for use in conjunction with its LION™ formulated repRNA (self-replicating RNA) vaccination platform. The ...
- Research combines DNA origami and photolithography to move one step closer to molecular computerson April 24, 2024 at 8:49 am
Molecular computer components could represent a new IT revolution and help us create cheaper, faster, smaller, and more powerful computers. Yet researchers struggle to find ways to assemble them more ...
- Sex and marriage patterns in an ancient empire revealed by DNAon April 24, 2024 at 8:47 am
Ancient DNA reveals new details about the Avars, fearsome warriors who built an empire that ruled Central and Eastern Europe for 250 years from the mid-sixth century.
- Vast DNA tree of life for plants revealed by global science team using 1.8 billion letters of genetic codeon April 24, 2024 at 8:00 am
A new paper published today (April 24) in the journal Nature by an international team of 279 scientists led by the Royal Botanic Gardens, Kew presents the most up-to-date understanding of the ...
- DNA Synthesis Approaches: Will New Methods Stand The Test Of Time?on April 24, 2024 at 6:00 am
Both chemical and enzymatic synthesis companies need to continue working to overcome their respective hurdles.
The Latest Google Headlines on:
Targeted cancer treatments
[google_news title=”” keyword=”targeted cancer treatments” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Targeted cancer treatments
- Study highlights differences in pancreatic cancer cells based on locationon April 30, 2024 at 9:47 pm
A new study has found that pancreatic cancer cells are different based on their location in the pancreas, providing new information about tumors that could lead to better targeted treatments.
- How the advancement in precision medicine is promising new hopes in breast cancer treatmenton April 30, 2024 at 8:13 pm
Breast cancer remains one of the most prevalent and deadly cancers affecting women worldwide. While traditional treatment approaches such as chemotherapy, surgery, and radiation therapy have been ...
- Rhode Island woman defeats the odds with new targeted cancer treatmenton April 30, 2024 at 8:00 pm
Doctors might call Ann Malik of Rhode Island an outlier; we would call her a thriver. Malik was diagnosed with stage four lung cancer at the age of 39, given just one month to live. Today, she is ten ...
- Woman describes toll of continued cancer treatments on her mental healthon April 30, 2024 at 1:02 pm
Mental health awareness month kicks off this week. For one breast cancer survivor, that means taking care of the body – and the brain.
- Development in cancer treatment focuses on re-educating cells to combat resistanceon April 30, 2024 at 10:09 am
In a development in cancer research, scientists are exploring new therapeutic strategies that move beyond traditional cytotoxic treatments, which have historically targeted uncontrolled cell ...
- Pfizer cervical cancer drug gets full approvalon April 30, 2024 at 8:56 am
The FDA has granted full approval for Pfizer's Tivdak (tisotumab vedotin-tftv) to treat cervical cancer in patients whose disease has progressed on or after chemotherapy.
- Adding Entinostat to ICI Dual Therapy Delivers Promising Responses in TNBCon April 30, 2024 at 6:00 am
Although immune checkpoint inhibitors have become a cornerstone of therapy across cancer settings, their use in most breast cancer settings has fallen short.
- Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinomaon April 24, 2024 at 2:18 pm
An interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the ...
- New 'targeted' cancer treatment 'represents real progress'on April 23, 2024 at 10:21 pm
The new drug therapy has been approved by the National Institute for Health and Care Excellence (Nice) after studies showed it lessened chemotherapy side-effects ...
- Targeted Therapy, Treatment Disparity Featured at Cancer Meetingon April 23, 2024 at 12:42 pm
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s ...